SCHEMBL7207983

SCHEMBL7207983

O=C(Nc1ccnc(Cl)n1)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.62
MEN1 O00255 2/20 0.62
RXFP1 Q9HBX9 1/20 0.54
NPC1 O15118 8/20 0.54
RAB9A P51151 8/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
PPARG P37231 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
NR2E3 Q9Y5X4 1/20 0.52
NCOR2 Q9Y618 1/20 0.52
JAK2 O60674 1/20 0.52
TYK2 P29597 1/20 0.52
HCAR3 P49019 1/20 0.50
LMNA P02545 1/20 0.49
KCNQ3 O43525 1/20 0.49
KCNQ2 O43526 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28687700 0.84 GRM5 (0.59) KMT2AMEN1RXFP1NPC1RAB9A
SCHEMBL18549055 0.82 KMT2A (0.64) KMT2AMEN1RXFP1NPC1RAB9A
SCHEMBL19073177 0.82 KMT2A (0.64) KMT2AMEN1RXFP1NPC1RAB9A
SCHEMBL821691 0.82 MEN1 (0.64) KMT2AMEN1RXFP1NPC1RAB9A
SCHEMBL15881317 0.81 GRM5 (0.48) KMT2ARXFP1L3MBTL1PPARGTDP1
SCHEMBL4648345 0.81 L3MBTL1 (0.51) KMT2AMEN1RXFP1NPC1RAB9A
SCHEMBL28650577 0.77 JAK2 (0.63) KMT2AMEN1NPC1RAB9AJAK2
SCHEMBL15890199 0.77 F2 (0.45) KMT2AMEN1TDP1LMNA
SCHEMBL821839 0.77 KMT2A (1.00) KMT2AMEN1RXFP1NPC1RAB9A
SCHEMBL28160772 0.76 GRM5 (0.44) KMT2ANPC1L3MBTL1PPARGTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921122-B1 EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2003-05-21 EP disclosed
US-6110967-A USEFUL AS AGENTS FOR PREVENTING AND TREATING METABOLIC OSTEOPATHY SUCH AS OSTEOPOROSIS, HYPERCALCEMIA AND BONE METASTASIS OF CANCER BECAUSE THEY SPECIFICALLY INHIBITS CATHEPSIN L AND ITS FAMILY ENZYMES TO INHIBIT BONE RESORPTION TAIHO PHARMACEUTICALS CO., LTD. (JP) 2000-08-29 US disclosed
EP-0921122-A1 NOVEL EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1999-06-09 EP disclosed